Spasticity in adults: management using botulinum toxin: national guidelines. London: Royal College of Physicians 2009.Turner-Stokes L, Ashford S, Bhakta B, et al. Spasticity in adults: management using botulinum toxin: national guidelines. Royal College of Physicians. 2009. London: Royal College ...
Before enrolling in the study, a neurologist thoroughly examined the patients and determined their suitability for receiving rTMS intervention based on the clinical safety guidelines put forward by Rossi et al. [65]. The criteria for receiving rTMS included: (1) no seizures, or a seizure-free pe...
The authors concluded that these preliminary results suggested that intensive WBV might potentially be a safe and feasible way to increase some aspect of lower limb muscle strength and postural control in adults with chronic stroke. Moreover, they stated that further studies should focus on evaluating...
The place of the botulinum toxin in the management of multiple sclerosis Multiple sclerosis (MS) is the most common disabling chronic disease of the central nervous system among young adults. These patients suffer from variety o... M Habek,A Karni,Y Balash,... - 《Clinical Neurology & Neuro...
The Spasticity Management Service at Walkergate Park undertook a retrospective audit against The National Best Practice Guidelines for Spasticity Management in Adults (2009) by reviewing 100 randomly selected new patient notes over a period of service change between 2009 and 2011. Identification in gaps...
Using this approach, velocity-dependence has been demonstrated in children with CP and adults with stroke (i.e., Jobin and Levin, 2000, Levin et al., 2000). Velocity-independence of the stretch reflex has only been shown in people with Parkinsonian rigidity (Mullick et al., 2013). In ...
in Palm Deformity.17When the Upper Limb is functional and the result of the procedure is expected to be improved function, the nerve supply to the targeted muscle needs to be reduced in order to reduce hypertonia but also maintain volitional control over the muscle. There is no consensus in...
Botulinum toxin (BoNT-A) has become first line of therapy in cervical dystonia, blepharospasm and spasticity. However, the current guidelines for the clini... M Relja,J Jacinto,J Jankovic,... - 《European Neurological Review》 被引量: 0发表: 2015年 Motor disorders: Evidence-based review of...
(2) Determine the safety and tolerability of iTBS over primary motor cortex on upper-limb function in people with spinal cord injury (SCI). Setting Large Tertiary Spinal Injuries Centre Methods Participants with incomplete SCI, suffering with upper-limb spasticity were recruited and randomized to ...
The product was first approved for the treatment of upper limb spasticity, consisting of increased muscle stiffness in the elbow, wrist, and fingers, in adults in March 2010. Additional FDA approval was received in April 2015 to expand the label for the treatment of adults with upper limb spas...